1. Brunt LM, Wells SA. Advances in the diagnosis and treatment of medullary thyroid carcinoma.Surg Clin North Am 1987; 67: 263–279.
2. Sisson JC, Ackermann R, Meyer MA, Wahl RL. Uptake of FDG by thyroid cancer: implications for diagnosis and therapy.J Clin Endocrinol Metab 1993; 77: 1090–1094.
3. Ohta H, Yamamato K, Endo K, Mori T, Hamanaka D, Shimazu A, Ikekubo K, Makimoto K, Lida Y, Konishi J, Morita R, Hata N, Horiuchi K, Yokoyama A, Torizuka K, Kuma K. A new imaging agent for medullary carcinoma of the thyroid.J Nucl Med 1984; 25: 323–325.
4. Clarke SEM, Lazarus CR, Wraight P, Sampson C, Maisey MN. Pentavalent [99mTc] DMSA, [131I]MIBG, and [99mTc] MDP — an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.J Nucl Med 1988; 29: 33–38.
5. Clarke SEM. Medullary thyroid cancer. In: Murray IPC, Ell PC, Strauss HW, eds.Nuclear medicine in clinical diagnosis and treatment. New York: Churchill Livingstone; 1994; 677–685.